EnerSpar Corp. (TSE:NRX) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
NurExone Biologic Inc. has received a Notice of Allowance from the Israel Patent Office for its ExoPTEN patent, a key component in its regenerative medicine therapy for acute spinal cord injuries. The company is advancing its ExoPTEN nanodrug towards clinical trials and has also partnered with Allele Capital Partners for investor relations services, with plans to increase engagement and potentially uplist to major stock exchanges.
For further insights into TSE:NRX stock, check out TipRanks’ Stock Analysis page.